<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39038980</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1544-1717</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Annals of family medicine</Title><ISOAbbreviation>Ann Fam Med</ISOAbbreviation></Journal><ArticleTitle>Post-COVID Conditions in US Primary Care: A PRIME Registry Comparison of Patients With COVID-19, Influenza-Like Illness, and Wellness Visits.</ArticleTitle><Pagination><StartPage>279</StartPage><EndPage>287</EndPage><MedlinePgn>279-287</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1370/afm.3131</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">COVID-19 is a condition that can lead to other chronic conditions. These conditions are frequently diagnosed in the primary care setting. We used a novel primary care registry to quantify the burden of post-COVID conditions among adult patients with a COVID-19 diagnosis across the United States.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used the American Family Cohort, a national primary care registry, to identify study patients. After propensity score matching, we assessed the prevalence of 17 condition categories individually and cumulatively, comparing patients having COVID-19 in 2020-2021 with (1) historical control patients having influenza-like illness in 2018 and (2) contemporaneous control patients seen for wellness or preventive visits in 2020-2021.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 28,215 patients with a COVID-19 diagnosis and 235,953 historical control patients with influenza-like illness. The COVID-19 group had higher prevalences of breathing difficulties (4.2% vs 1.9%), type 2 diabetes (12.0% vs 10.2%), fatigue (3.9% vs 2.2%), and sleep disturbances (3.5% vs 2.4%). There were no differences, however, in the postdiagnosis monthly trend in cumulative morbidity between the COVID-19 patients (trend = 0.026; 95% CI, 0.025-0.027) and the patients with influenza-like illness (trend = 0.026; 95% CI, 0.023-0.027). Relative to contemporaneous wellness control patients, COVID-19 patients had higher prevalences of breathing difficulties and type 2 diabetes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings show a moderate burden of post-COVID conditions in primary care, including breathing difficulties, fatigue, and sleep disturbances. Based on clinical registry data, the prevalence of post-COVID conditions in primary care practices is lower than that reported in subspecialty and hospital settings.</AbstractText><CopyrightInformation>&#xa9; 2024 Annals of Family Medicine, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Vel&#xe1;squez</LastName><ForeName>Esther E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Center for Population Health Sciences, Stanford School of Medicine, Stanford University, Palo Alto, California evelasq@stanford.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kamdar</LastName><ForeName>Neil S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Center for Population Health Sciences, Stanford School of Medicine, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehkopf</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Center for Population Health Sciences, Stanford School of Medicine, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Population Health, Stanford School of Medicine, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CDC COVID-19 Response Team, Center for Surveillance, Epidemiology, and Laboratory Services, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bull-Otterson</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CDC COVID-19 Response Team, Center for Surveillance, Epidemiology, and Laboratory Services, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Shiying</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Population Health Sciences, Stanford School of Medicine, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vala</LastName><ForeName>Ayin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Population Health Sciences, Stanford School of Medicine, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Population Health Sciences, Stanford School of Medicine, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazemore</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>American Board of Family Medicine, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>American Board of Family Medicine, Lexington, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boehmer</LastName><ForeName>Tegan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CDC COVID-19 Response Team, Center for Surveillance, Epidemiology, and Laboratory Services, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Fam Med</MedlineTA><NlmUniqueID>101167762</NlmUniqueID><ISSNLinking>1544-1709</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic illness</Keyword><Keyword MajorTopicYN="N">family practice</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">morbidity</Keyword><Keyword MajorTopicYN="N">post-COVID conditions</Keyword><Keyword MajorTopicYN="N">post-infectious disorders</Keyword><Keyword MajorTopicYN="N">primary health care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>21</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39038980</ArticleId><ArticleId IdType="pmc">PMC11268691</ArticleId><ArticleId IdType="doi">10.1370/afm.3131</ArticleId><ArticleId IdType="pii">22/4/279</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The New York Times . Track Covid-19 in the U.S. The New York Times. Published Mar
22, 2023. Accessed Sep 27, 2023. https://www.nytimes.com/interactive/2023/us/covid-cases.html</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. U.S. Department of Health and Human Services . COVID Data Tracker. Published 2023. Accessed Oct 27, 2023. https://covid.cdc.gov/covid-data-tracker</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM.. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-1242. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021; 4(2): e210830. 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of post-acute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021; 4(10): e2128568. 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; United States, March 2020&#x2013;November 2021. MMWR Morb Mortal Wkly Rep. 2022; 71(21); 713-717. 10.15585/mmwr.mm7121e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, et al. . Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022; 28(5): 657-666. 10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Government Accountability Office . Science &amp; tech spotlight: long COVID. Published Mar
2, 2022. Accessed Sep 26, 2022. https://www.gao.gov/products/gao-22-105666</Citation></Reference><Reference><Citation>Tenforde MW, Devine OJ, Reese HE, et al. . Point prevalence estimates of activity-limiting long-term symptoms among United States adults &#x2265;1 month after reported severe acute respiratory syndrome coronavirus 2 infection, 1 November 2021. J Infect Dis. 2023; 227(7): 855-863. 10.1093/infdis/jiac281</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac281</ArticleId><ArticleId IdType="pmc">PMC9278232</ArticleId><ArticleId IdType="pubmed">35776165</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022; 28(8): 1706-1714. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC.. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021; 52(6): 575-581. 10.1016/j.arcmed.2021.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021; 27(4): 601-615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N, et al. . 
In the Wake of the Pandemic: Preparing for Long COVID. World Health Organization, Regional Office for Europe; 2021: 25. Policy Brief
39. Accessed Dec 14, 2021. https://apps.who.int/iris/bitstream/handle/10665/339629/Policy-brief-39-1997-8073-eng.pdf</Citation></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN.. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021; 4(5): e2111417. 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B.. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021; 594(7862): 259-264. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, et al. . Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022; 376: e068414. 10.1136/bmj-2021-068414</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. L. Erlbaum Associates; 1988.</Citation></Reference><Reference><Citation>Sullivan GM, Feinn R.. Using effect size-or why the P value is not enough. J Grad Med Educ. 2012; 4(3): 279-282. 10.4300/JGME-D-12-00156.1</Citation><ArticleIdList><ArticleId IdType="doi">10.4300/JGME-D-12-00156.1</ArticleId><ArticleId IdType="pmc">PMC3444174</ArticleId><ArticleId IdType="pubmed">23997866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DK. Alternatives to P value: confidence interval and effect size. Korean J Anesthesiol. 2016; 69(6): 555-562. 10.4097/kjae.2016.69.6.555</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2016.69.6.555</ArticleId><ArticleId IdType="pmc">PMC5133225</ArticleId><ArticleId IdType="pubmed">27924194</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Implementing High-Quality Primary Care . Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. Robinson SK, Meisnere M, Phillips RL, McCauley L, eds. National Academies Press; 2021. Accessed Oct 11, 2023. https://www.ncbi.nlm.nih.gov/books/NBK571810/</Citation><ArticleIdList><ArticleId IdType="pubmed">34251766</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen ME, Kircher SM, Huerta TR.. Reexamining the ecology of medical care. N Engl J Med. 2016; 374(5): 495-496. 10.1056/NEJMc1506109</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1506109</ArticleId><ArticleId IdType="pubmed">26840150</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, et al. . Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2013;a systematic review and meta-analysis. J Med Virol. 2022; 94(1): 253-262. 10.1002/jmv.27309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021; 11(1): 16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al. . Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023; 183(6): 566-580. 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>